GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Inventories, Raw Materials & Components

Radiopharm Theranostics (ASX:RAD) Inventories, Raw Materials & Components : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Inventories, Raw Materials & Components?

Radiopharm Theranostics's inventories, raw materials & components for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Radiopharm Theranostics Inventories, Raw Materials & Components Historical Data

The historical data trend for Radiopharm Theranostics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Inventories, Raw Materials & Components Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
Inventories, Raw Materials & Components
- -

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components - - - - -

Radiopharm Theranostics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Radiopharm Theranostics (ASX:RAD) Business Description

Industry
Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines